Stock market week-in-review for 5 large GI companies — Sept. 11-15

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 11 to Sept 15, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $236.08 on Sept. 11
Peaked at open
Closed: $ 220.07 on Sept. 15
Percent change between Sept. 11 and Sept. 15: -6.78 percent

2. Exact Sciences Corp.

Opened: $43.39 on Sept. 11
Peaked at open
Closed: $42.80 on Sept. 15
Percent change between Sept. 11 and Sept. 15: -1.35 percent

3. Johnson & Johnson

Opened: $131.34 on Sept. 11
Peaked: $125.19 on Sept. 15
Closed: $134.54 on Sept. 15
Percent change between Sept. 11 and Sept. 15: 2.43 percent

4. Synergy Pharmaceuticals

Opened: $2.80 on Sept. 11
Peaked: $2.89 on Sept. 12
Closed: $2.70 on Sept. 15
Percent change between Sept. 11 and Sept. 15: -3.47 percent

5. Valeant Pharmaceuticals

Opened: $14 on Sept. 11
Peaked: $14.60 on Sept. 12
Closed: $13.90 on Sept. 15
Percent change between Sept. 11 and Sept. 15: -0.71 percent

More articles on gastroenterology: 
How Exact Sciences’ Cologuard has a higher compliance rate than traditional CRC screening method
GI leader to know: Dr. Timothy Halterman of Gastroenterology Consultants
National Institute of Environmental Health Sciences awards Dr. Matthew Cave $4.01M grant — 5 key notes

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.